What's breaking now, across thousands of outlets.
A new report found that the sizes of seed rounds and Series A financings for Massachusetts biotech startups are going in opposite directions, as funding slows for young companies with the “riskiest science.”
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
NHS has target of eliminating the cancer by 2040, but up to 4 million eligible women are not up to date with screening Millions of women in England who have missed cervical screening appointments will…
The Transmitter ’s summer reading list includes an autopsy of the Human Brain Project, an overview of the neuroscience of motherhood and a memoir from a pioneer in Huntington’s disease research.
Here is a roundup of autism-related news and research spotted around the web for the week of 24 August.
President John Dramani Mahama on Monday opened the 28th Annual Conference of the Association of Medical Councils of Africa (AMCOA) in Accra with a call on African nations to take charge of and protect…
Salman Khan always wins hearts with his kindness. This time, the Bollywood superstar stepped in to support his longtime body double, Parvez Kazi, after he fell ill amid the ongoing shoot of Khan's…
Celltrion is expanding the 300mg formulation of its omalizumab biosimilar Omlyclo across major European markets, a move that could help the South Korean biopharmaceutical company convert its…
